[1]  Coussens LM, Werb Z. Inflammation and cancer[J]. Nature,2002,420(6917):860-867.
[2] Sica A, Schioppa T, Mantovani A, et al. Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: Potential targets of anti-cancer therapy[J]. Eur J Cancer, 2006,42(6):717-727.
[3] Mantovani A, Sozzani S, Locati M, et al. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes[J]. Trends Immunol, 2002, 23(11):549-555.
[4] Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer[J]. Cell, 2010,140(6):883-899.
[5] Mitre-Aguilar IB, Cabrera-Quintero AJ, Zentella-Dehesa A. Genomic and non-genomic effects of glucocorticoids: implications for breast cancer[J]. Int J Clin Exp Pathol, 2015, 8(1):1-10.
[6] Smoak KA, Cidlowski JA. Mechanisms of glucocorticoid receptor signaling during inflammation[J]. Mech Ageing Dev, 2004, 125(10-11):697-706.
[7] Wang H, Wang X, Li X, et al. CD68+HLA-DR+ M1-like macrophages promote motility of HCC cells via NF-κB/FAK pathway[J]. Cancer Lett, 2014, 345(1):91-99.
[8]  郑飞，周文平，张巍，等. 大鼠肝癌诱导过程中肝癌干细胞标志及炎症因子的动态变化[J]. 中国组织工程研究, 2015, (19):3005~3009.
[9] Zhang N, Sun Q, Chen Z, et al. Homeostatic regulatory role of Pokemon in NF-κB signaling: stimulating both p65 and IκBα expression in human hepatocellular carcinoma cells[J]. Mol Cell Biochem, 2013, 372(1-2):57-64.
[10] Wang M. Human progenitor cells from bone marrow or adipose tissue produce VEGF, HGF, and IGF-I in response to TNF by a p38 MAPK-dependent mechanism[J]. Am J Physiol Regul Integr Comp Physiol, 2006, 291(4):R880-884.